NDC 64679-630-01 - ADENOSINE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 64679-630
- Requested NDC
- 64679-630-01
- Package NDCs from labels
- 64679-630-01, 64679-630-07, 64679-630-02, 64679-630-08
- Manufacturer
- WOCKHARDT USA LLC.
- Effective date
- 2012-10-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Adenosine Injection, USP FOR RAPID BOLUS INTRAVENOUS USE | WOCKHARDT USA LLC. | 2012-10-30 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 64679-630-01 | ADENOSINE | 2 mL in 1 SYRINGE, GLASS | INJECTION | 2 | 2 | |
| 64679-630-02 | ADENOSINE | 4 mL in 1 SYRINGE, GLASS | INJECTION | 4 | 2 | |
| 64679-630-07 | ADENOSINE | 10 in 1 CARTON | INJECTION | 10 | 2 | |
| 64679-630-08 | ADENOSINE | 10 in 1 CARTON | INJECTION | 10 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 64679-630-01 | ML - Milliliter | 64679-630 | 0c2afb51-29fe-4fd3-9679-177f373d451d | 1 | 2012-07-24 |
| 64679-630-02 | ML - Milliliter | 64679-630 | a3f673fb-08ad-4969-9bd3-1168d7b253cc | 1 | 2012-07-24 |
| 64679-630-07 | ML - Milliliter | 64679-630 | 9a226a59-5fe2-4e82-b54b-fd758fa54421 | 1 | 2012-07-24 |
| 64679-630-08 | ML - Milliliter | 64679-630 | 4894a0be-8cc4-4871-8236-6b3f2ed4a931 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ADENOSINE | ACTIVE INGREDIENT | K72T3FS567 | ADENOSINE INJECTION [WOCKHARDT USA LLC.] | 2 | |
| ADENOSINE | ACTIVE MOIETY | K72T3FS567 | ADENOSINE INJECTION [WOCKHARDT USA LLC.] | 2 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | ADENOSINE INJECTION [WOCKHARDT USA LLC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium Chloride | SODIUM CHLORIDE | Baxter Healthcare Company | 886f889b-f3cf-4197-b307-6cfa88c89436 | 2017-05-04 | 451W47IQ8X | |
| ReHydration | ADENOSINUM CYCLOPHOSPHORICUM, COFFEA CRUDA, GLANDULA SUPRARENALIS SUIS, HYPOTHALAMUS (BOVINE), KALI PHOSPHORICUM, NATRUM MURIATICUM, SARSAPARILLA, SILICEA, TARAXACUM OFFICINALE, THYROIDINUM (BOVINE) | Energetix Corp | 9883c502-9782-451e-9eec-c54d7b054f31 | 2017-01-31 | Warnings | 451W47IQ8X |
| Tox-Chord | ALFALFA, ALUMINA, BENZOICUM ACIDUM, CARBONEUM, CETRARIA ISLANDICA, FOLLICULINUM, FUCUS VESICULOSUS, FUMARICUM ACIDUM, HEPAR SUIS, KALI CARBONICUM, KREOSOTUM, NATRUM MURIATICUM, PARAFFINUM, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, PIX LIQUIDA, PLANTAGO MAJOR, PLUMBUM METALLICUM, PULSATILLA (VULGARIS), RADIUM BROMATUM, RESORCINUM, SALOL, SILICEA, SYMPHYTUM OFFICINALE, TABACUM, TEREBINTHINA, THYROIDINUM (BOVINE), TRITICUM REPENS, ZINCUM OXYDATUM | Energetix Corp | 6b0d1628-b20d-426e-9c84-5cceadca3f45 | 2016-11-11 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Baxter Healthcare Corporation | 2a96096d-43cc-49b7-af53-b53c17f41001 | 2014-07-25 | Warnings, Adverse reactions | 451W47IQ8X |
| SODIUM CHLORIDE | SODIUM CHLORIDE | Baxter Healthcare Corporation | b3b4b176-41f0-4ca8-90d4-3fba5707564a | 2014-02-21 | 451W47IQ8X | |
| TIS-U-SOL | SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, SODIUM PHOSPHATE, AND POTASSIUM PHOSPHATE | Baxter Healthcare Corporation | 9da4121f-d62d-4da4-8dfb-0494da16015f | 2014-02-21 | 451W47IQ8X | |
| c228eecc-e21a-48e4-b775-d0ee282b3346 | ca4520ad-7f42-4632-8065-5b88a0ca7f2f | 2012-10-30 | Warnings, Adverse reactions | c228eecc-e21a-48e4-b775-d0ee282b3346 ca4520ad-7f42-4632-8065-5b88a0ca7f2f | ||
| Ringers | SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, | Baxter Healthcare Corporation | e1953d54-818d-46a6-8532-518ebae6d84e | 2012-06-13 | 451W47IQ8X | |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | Baxter Healthcare Corporation | f09f80bf-2f8b-4420-865d-aec2d5e5cd4d | 2012-06-12 | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.